Rocket Fuel


Print    Email
Decrease (-) Restore Default Increase (+)

Lymphoma Clinical Trials

Please check with your doctor or call 1-855-HCH-HOPE (424-4673) to find out if you qualify for any of these studies.

Trial  #

Trial Sub-type




Small lymphocytic, lymphoplasmacytic, marginal zone lymphoma, and follicular
lymphoma (FL); grades 1, 2 and 3A

Clinical trial of OfatuMumab and bendamustine in Patients with indolent NHL that is refractory to other treatment A Randomized, Open Label Study of Ofatumumab and Bendamustine Combination Therapy Compared with Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin’s Lymphoma Unresponsive to Rituximab or a Rituximab-Containing Regimen During or Within Six Months of Treatment

 ECOG E1411

Mantle Cell Lymphoma
Front - line Patients ³ 60

Intergroup Randomized Phase II Four Arm Study In Patients ³ 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR). Learn more.

©  2014 

Holy Cross Hospital | 1500 Forest Glen Road, Silver Spring, MD 20910 | 301-754-7000